{"id":17295,"date":"2026-06-08T14:11:00","date_gmt":"2026-06-08T12:11:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=d82b994c531ce67df92eec60718b756e"},"modified":"2026-06-08T14:11:00","modified_gmt":"2026-06-08T12:11:00","slug":"haleon-invests-in-india-to-deliver-better-everyday-health-to-rural-communities","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=17295","title":{"rendered":"Haleon Invests in India to Deliver Better Everyday Health to Rural Communities"},"content":{"rendered":"<ul class=\"bwlistdisc\">\n<li>\n<b>\u00a3175m for first Haleon manufacturing site in Madhya Pradesh, central India<\/b><\/li>\n<li>\n<b>Fast-growing India key to Haleon reaching one billion more consumers by 2030<\/b><\/li>\n<li>\n<b>India\u2019s consumer health market to reach over \u00a323bn by 2030<sup>1<\/sup><\/b><\/li>\n<li>\n<b>Accelerated rural distribution to access 3 million outlets<\/b><\/li>\n<li>\n<b>Affordable Sensodyne packs and investment to double \u2018last-mile\u2019 reach in rural areas<\/b><\/li>\n<\/ul><p>LONDON--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/hashtag\/AI?src=hash\" >#AI<\/a>--Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately \u00a3175 million<sup>2<\/sup> in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825698\/5\/HJKK6687.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825698\/22\/HJKK6687.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825698\/5\/HJKK6687.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825698\/21\/HJKK6687.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825694\/5\/H_MasterLogo_Colour_POS_RGB.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825694\/22\/H_MasterLogo_Colour_POS_RGB.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825694\/5\/H_MasterLogo_Colour_POS_RGB.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260608753094\/en\/2825694\/21\/H_MasterLogo_Colour_POS_RGB.jpg\" \/><\/a><p>\n<b>Building capacity to meet rising demand<\/b><\/p><p>\nThe new site, which is well-positioned in the middle of the country and close to some of India\u2019s most renowned technical colleges, marks an important step in the delivery of Haleon\u2019s Win as One strategy. Win as One focuses on unlocking growth, driving productivity and transforming the company\u2019s culture. Strengthening its in-house supply chain capabilities will enable Haleon to be more resilient and able to adapt faster to consumer needs.<\/p><p>\nHaleon\u2019s investment in India reflects the clear, structural shift towards prevention and daily self-care, with the country\u2019s consumer health market expected to reach over \u00a323 billion by 2030. India is already one of Haleon\u2019s largest oral health markets and this latest investment will accelerate access to its portfolio of trusted, science-backed brands including <i>Sensodyne<\/i> and <i>parodontax<\/i> across rural communities, with ambitions to reach more than three million outlets by 2030.<\/p><p>\nThe investment is in line with Haleon\u2019s capital allocation priorities as outlined at the company\u2019s Capital Markets Day in 2025.<\/p><p>\n<b>Reaching underserved communities at scale<\/b><\/p><p>\nRural India is home to around 65% of the country\u2019s population<sup>3<\/sup>, spread across more than 650,000 villages<sup>4<\/sup>, where unmet oral health needs remain significant. Access to dental care remains highly limited in rural India, where a single dentist may serve around 250,000 people<sup>5<\/sup>. With as few as 1 in 7 people in rural communities<sup>6<\/sup> visiting a dentist each year, many live with untreated conditions like tooth decay or sensitivity for years. With many not currently using specialist toothpaste such as <i>Sensodyne,<\/i> recommended by healthcare professionals, there is a significant opportunity to address unmet consumer needs.<\/p><p>\nWith many households reliant on daily wages and increasingly value conscious, Haleon will also be rolling out access to high-quality, science based oral health products made with trusted ingredients through lower-cost, small-format toothpaste packs \u2013 including its 20-rupee <i>Sensodyne<\/i> pack \u2013 across significantly more towns and villages.<\/p><p>\nWith sales and distribution teams now working directly into Haleon\u2019s leadership, there is significant opportunity to transform how products reach consumers in new and innovative ways \u2013 supported by the recruitment of more than 500 people to its sales teams over the last 12 months.<\/p><p>\n<b>\u2018Last-mile\u2019 investment to build awareness and access<\/b><\/p><p>\nHaleon is also investing in \u2018last-mile\u2019 capabilities, doubling frontline teams on motorbikes who are equipped with testing kits, samples and diagnostic tools and deployed to rural areas, which are often beyond the reach of traditional retail and pharmacies. Simple diagnostic tools, such as \u2018chill tests\u2019 \u2013 where consumers assess sensitivity by drinking cold water - help consumers recognise symptoms they may have had for years and connect them with science-backed treatment, often for the first time.<\/p><p>\nThe company is also improving access by engaging rural communities directly through education, with its network of mobile oral health literacy vans. These<i> Sensodyne<\/i>-branded vans are designed to turn local squares and marketplaces into community hubs for oral health awareness, sensitivity and gum health checks, and immediate access to products.<\/p><p>\n<b>Brian McNamara, CEO, Haleon, said:<\/b> <i>\u201cIndia is a key strategic market for Haleon and an important driver of our long-term growth. This investment strengthens our local manufacturing footprint and expands our reach in one of the world\u2019s fastest-growing consumer health markets. By increasing access to our trusted brands and building our capabilities on the ground, we are well positioned to capture the significant opportunities ahead.<\/i><\/p><p>\n<i>\u201cWe aim to expand access to better everyday health for more than 300 million additional consumers in India. This will be key to achieving<b> <\/b>our broader ambition to reach one billion more consumers globally by 2030.\u201d<\/i><\/p><p>\nThe new manufacturing facility was marked by a groundbreaking ceremony and a meeting between Haleon management and the Chief Minister of Madhya Pradesh this week. It will create up to 500 jobs, strengthen local capabilities and support long-term economic development, reinforcing Haleon\u2019s ambition to be an employer of choice in the country. It is expected to open in early 2028 with supply commencing the following year.<\/p><p>\n<b>Notes to editors Q&amp;A<\/b><\/p><p>\n<b><i>Why is Haleon investing in India?<\/i><\/b><\/p><p>\n<i>India is one of Haleon\u2019s fastest growing markets and key to achieving its ambition to reach one billion more consumers by 2030. The country\u2019s consumer health market is forecast to reach over \u00a323 billion by 2030, driven by rising awareness and adoption of self-care. Significant unmet health needs in rural areas, where access to care remains limited and many consumers do not yet use specialist products, create substantial headroom for growth and an opportunity to expand access to everyday health.<\/i><\/p><p>\n<b><i>How much is Haleon investing in India, and how will this investment be phased?<\/i><\/b><\/p><p>\n<i>Haleon is investing around \u00a3175 million of capital expenditure in a new oral health manufacturing site in Madhya Pradesh. This investment will be phased across the 2025 \u2013 2029 period. The site is expected to open in early 2028, with supply commencing the following year, supporting the company\u2019s long-term growth plans in India. The investment is in line with Haleon\u2019s capital allocation priorities as outlined at the company\u2019s Capital Markets Day in 2025.<\/i><\/p><p>\n<b><i>How will this investment support Haleon\u2019s growth strategy?<\/i><\/b><\/p><p>\n<i>The investment supports Haleon\u2019s Win as One strategy by strengthening in-house supply chain capabilities and enabling faster response to consumer needs. It also forms part of Haleon\u2019s \u2018Build for Tomorrow\u2019 programme, which is transforming Haleon\u2019s global supply chain to meet mid- to long-term needs, including through investments in key growth markets such as India and China.<\/i><\/p><p>\n<b><i>Will the new manufacturing site support exports to other markets?<\/i><\/b><\/p><p>\n<i>The new site focuses on meeting growing demand within India, one of our fastest-growing markets, while also serving other parts of Asia. The site strengthens local manufacturing capabilities and supply chain resilience, while forming part of our broader global supply chain transformation.<\/i><\/p><p>\n<b><i>How does this investment strengthen Haleon\u2019s presence in India?<\/i><\/b><\/p><p>\n<i>We actively invest in markets where we see opportunities to drive innovation and create value. This investment strengthens Haleon\u2019s capabilities in India by expanding local manufacturing and building a more localised, resilient supply network closer to consumers. It enhances agility to meet growing demand - particularly in underserved and rural communities - while supporting the company\u2019s broader efforts to optimise and transform its global supply chain.<\/i><\/p><p>\n<b><i>How many people does Haleon employ in India, and will this investment create jobs?<\/i><\/b><\/p><p>\n<i>Haleon already employs a significant workforce across India. The new manufacturing site will create 500 jobs and strengthen local capabilities. In addition, the company has recruited more than 500 people into its sales teams over the last 12 months to support expanded distribution.<\/i><\/p><p>\n<b><i>How does this announcement build on Haleon\u2019s existing presence in India?<\/i><\/b><\/p><p>\n<i>Since becoming a standalone company in 2022, Haleon has redefined its presence in India - building its own end-to-end dedicated salesforce and distribution network. This investment builds on that foundation, strengthening route-to-market and accelerating rural outreach to reach more underserved communities.<\/i><\/p><p>\n<b><i>Why have you selected Madhya Pradesh as the location for the new site?<\/i><\/b><\/p><p>\n<i>Madhya Pradesh is well-positioned in the centre of the country with the site selected due to its close proximity to infrastructure, higher education, logistics, talent and incentives.<\/i><\/p><p>\n<b><i>Where does India sit within Haleon\u2019s global operating model?<\/i><\/b><\/p><p>\n<i>Haleon\u2019s new operating model \u2013 announced early this year - established India Subcontinent as a distinct Operating Unit, reporting directly into the Chief Executive, reflecting the scale and growth potential of the market and reinforcing the strategic importance of this investment.<\/i><\/p><p>\n<b>About Haleon<\/b><\/p><p>\nHaleon (LSE\/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as <i>Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu<\/i> and<i> Voltaren<\/i> \u2013 are trusted by more than one billion consumers and are recommended by health professionals around the world.<\/p><p>\nFor more information, please visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.haleon.com&amp;esheet=54549065&amp;newsitemid=20260608753094&amp;lan=en-US&amp;anchor=www.haleon.com&amp;index=1&amp;md5=7ee8e859102125aff45495f4ab6d4373\" rel=\"nofollow\" shape=\"rect\">www.haleon.com<\/a><\/p><table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwcellpmargin\">\n<sup>1<\/sup> Source: IQVIA Market Prognosis (consumer health), India, 2024\u20132030 estimates.<\/p><\/td><\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwcellpmargin\">\n<sup>2<\/sup> \u00a3175m reflects gross Investment at 1 Pound = INR 115<\/p><\/td><\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwcellpmargin\">\n<sup>3<\/sup> <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1894901%26reg%3D3%26lang%3D2&amp;esheet=54549065&amp;newsitemid=20260608753094&amp;lan=en-US&amp;anchor=Press+Release+Page+%7C+Press+Information+Bureau&amp;index=2&amp;md5=231b435a57b1e7cb96601d39e835aa66\" rel=\"nofollow\" shape=\"rect\">Press Release Page | Press Information Bureau<\/a><\/p><\/td><\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwcellpmargin\">\n<sup>4<\/sup> <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pib.gov.in%2FPressReleseDetailm.aspx%3FPRID%3D2039629%26reg%3D3%26lang%3D1&amp;esheet=54549065&amp;newsitemid=20260608753094&amp;lan=en-US&amp;anchor=Press+Release%3A+Press+Information+Bureau&amp;index=3&amp;md5=01412c5f6182054ff1cc34597b4174f2\" rel=\"nofollow\" shape=\"rect\">Press Release: Press Information Bureau<\/a><\/p><\/td><\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwcellpmargin\">\n<sup>5<\/sup> <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.academia.edu%2F51768290%2FAn_Overview_of_Oral_Health_in_India_Current_Scenario_and_Challenges&amp;esheet=54549065&amp;newsitemid=20260608753094&amp;lan=en-US&amp;anchor=%28PDF%29+An+Overview+of+Oral+Health+in+India%3A+Current+Scenario+and+Challenges&amp;index=4&amp;md5=932f842bd5bca004e68711bec236e40c\" rel=\"nofollow\" shape=\"rect\">(PDF) An Overview of Oral Health in India: Current Scenario and Challenges<\/a><\/p><\/td><\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><p class=\"bwcellpmargin\">\n<sup>6<\/sup> <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12220351%2F&amp;esheet=54549065&amp;newsitemid=20260608753094&amp;lan=en-US&amp;anchor=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12220351%2F&amp;index=5&amp;md5=42aba72d67ef8bb9fe018e33f93ec8a8\" rel=\"nofollow\" shape=\"rect\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12220351\/<\/a><\/p><\/td><\/tr>\n<\/table><p>\n\u00a0<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nPhilippa Keir - <a  href=\"mailto:philippa.l.keir@haleon.com\" rel=\"nofollow\" shape=\"rect\">philippa.l.keir@haleon.com<\/a> - +447969271455\n<br\/>Victoria Durman - <a  href=\"mailto:victoria.a.durman@haleon.com\" rel=\"nofollow\" shape=\"rect\">victoria.a.durman@haleon.com<\/a> - +447894505730<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a3175m for first Haleon manufacturing site in Madhya Pradesh, central India<\/p>\n<p>Fast-growing India key to Haleon reaching one billion more consumers by 2030<\/p>\n<p>India\u2019s consumer health market to reach over \u00a323bn by 20301<\/p>\n<p>Accelerated rural distribution to a&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-17295","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/17295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17295"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/17295\/revisions"}],"predecessor-version":[{"id":17296,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/17295\/revisions\/17296"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}